A man in his forties with advanced liver disease presented with progressive low back pain of four months’ duration and recent gait impairment. He had Child-Pugh C alcoholic cirrhosis and was awaiting liver transplantation; diabetes mellitus was controlled. The patient occasionally assisted on his father’s cattle farm and reported no recent travel abroad. Initial computed tomography suggested L4–L5 discovertebral involvement with erosion of the superior L5 end-plate and right perivertebral tissue infiltration. Magnetic resonance imaging confirmed anterior epidural inflammatory infiltration, canal narrowing, right neural foramen extension, and a right psoas muscle abscess. These findings established a radiologic pattern consistent with discovertebral infection with secondary abscess formation.
The clinical picture lacked overt sepsis or frank neurologic compression at presentation. Multiple sets of blood cultures were negative. Because the first computed tomography–guided vertebral biopsy (performed 10 days after MRI) produced negative bacteriology, mycology, and histology, clinicians proceeded to obtain a second biopsy one month later. That repeat sampling proved diagnostically decisive.
Aerobic culture of the second biopsy, incubated at 37°C with 5% CO2, yielded growth of a small gram-negative bacillus after an extended 62-hour incubation. Colonies were described as gray, translucent, smooth, and nonhemolytic; the organism was oxidase- and catalase-positive and strictly aerobic, with fastidious growth on Drigalski and bromocresol purple media. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry failed to provide an identification. The report noted that mycologic cultures and targeted PCRs for Aspergillus species and Mucorales were negative, despite repeated positive panfungal blood markers (β-D-glucan and galactomannan antigen); those serologic signals did not correspond to a fungal isolate in tissue.
Investigators performed 16S rRNA sequencing and whole-genome analysis on the isolate labeled FR25DVI. Phylogenetic analysis placed FR25DVI near a previously reported human Camelimonas strain (ID_303_24) but distinct from described type strains such as C. lactis and C. fluminis. Genome size was reported as 4,292,006 base pairs with 63% GC content. Average nucleotide identity (ANI) and digital DNA–DNA hybridization (dDDH) comparisons with available Camelimonas genomes yielded values below accepted cutoffs for species delineation, indicating that FR25DVI likely represents a novel Camelimonas species closely related to a previously described human isolate.
The authors emphasized repeated microbiological isolation and genomic confirmation from two biopsies as evidence for the organism’s pathogenic role in this bone infection.
Antibiotic susceptibility testing returned low MICs: TMP/SMX 0.016 mg/L, doxycycline 0.25 mg/L, and amoxicillin 2 mg/L. Empiric treatment was guided by these results. The clinical team initiated oral TMP/SMX (800/160 mg three times daily) combined with doxycycline (100 mg twice daily). TMP/SMX was discontinued after eight days because the patient experienced renal deterioration; the regimen was changed to high-dose amoxicillin (2 g four times daily) plus doxycycline for a total antimicrobial course of six weeks. The patient also used a rigid brace during treatment.
The 6-week amoxicillin/doxycycline regimen was reported as well tolerated after the change and produced symptomatic improvement with stabilization of MRI lesions. Antibiotics were discontinued at the end of the planned course. At six-month follow-up, the patient had no evidence of disease progression though residual lumbar pain persisted.
The authors noted that no standardized antibiotic guidelines exist for Camelimonas infections; treatment decisions prioritized agents with oral bioavailability and bone penetration. They reported that renal dysfunction required modification of the initial, culture-guided plan.
The case report contextualized the finding within previous isolations of Camelimonas: first described in camel milk, later identified in environmental samples, bovine placenta, and once from human blood. Investigators reported that cattle are a recognized reservoir for the bacterium, and the patient’s occasional farm exposure supported a plausible zoonotic link. The authors stated possible transmission routes as direct contact with infected animals or ingestion of contaminated raw milk; however, no definitive epidemiologic trace or illness in the herd was documented.
Given the patient’s underlying liver disease and presumed relative immunosuppression, investigators suggested an increased susceptibility to invasive infection. The report also discussed the organism’s apparent affinity for collagen-rich tissues—vertebrae and intervertebral disks—proposing that such substrates might favor bacterial adhesion and colonization, consistent with the clinical presentation observed.
This report describes a single case; the authors acknowledged scarcity of human Camelimonas reports and the absence of standardized treatment protocols. The source did not provide controlled comparative data on optimal antibiotic choice, duration, or outcomes, nor did it document a confirmed transmission pathway from animals to this patient. Panfungal serum markers were repeatedly positive despite negative mycologic cultures, and the authors did not resolve that discordance. No population-level surveillance data were provided to estimate incidence or prevalence in humans or livestock.
Remaining questions the study team identified include: the true incidence of human infection by Camelimonas species; the definitive reservoirs and routes of transmission; mechanisms underlying any bone tropism; and evidence-based antibiotic regimens and durations for invasive infections. The authors recommend enhanced microbiologic vigilance, repeat sampling when initial biopsies are nondiagnostic, genome sequencing for unusual isolates, and epidemiologic investigation when Camelimonas is identified, but the report did not specify formal surveillance steps or regulatory milestones.